glp-1 gip muscle preservation therapies 2025 And Monthly Weight Loss Program Nutritional priorities to support GLP-1

The population in SELECT was different that STEP-1 and SUMOUNT 1, with 90.1% of patients on lipid-lowering therapy and a much lower baseline LDL-C of 78 mg/dL compared to 111 mg/dL and 110 mg/dL in STEP-1 and SURMOUNT 1 respectively [33, 35, 48]

Some people lose more than 100 pounds in the first year, particularly those who started at higher weights and responded well to the medication

The stakes are real: semaglutide and tirzepatide are peptide medications that degrade when exposed to heat, freezing, or prolonged light exposure

One of the biggest challenges when figuring out these statistics is the fact that both diabetes and GLP-1 inhibitors can result in delayed gastric emptying